A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia.
针对 CD7 和 CD33 的双特异性抗体药物偶联物在侵袭性急性髓系白血病亚型中显示出抗肿瘤活性和提高的肿瘤选择性
期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2025.2551205
Griffiths Hollie B S, Jones Nyle, Vitale Mattia, Faulkner Nikhil, Masters Edward W, Nabi-Aldridge Naomi L A, Mistry Meera, Patterson Chloe, Blanco-Gomez Adrian, Griessinger Emmanuel, Schon Oliver, Daniels-Thorn Tiffany J
